Contact organization for eligibility
This article highlights groundbreaking research on tuberculosis (TB) treatment, revealing why a key TB drug remains effective against resistant strains. Rutgers Health researchers uncover the molecular mechanisms that enable this drug to combat TB bacteria, potentially inspiring improved treatments and drug development strategies. The findings emphasize the need for continued research to address antibiotic resistance and enhance global TB control efforts.
This toolkit serves as a comprehensive resource for communities affected by tuberculosis. It offers practical tools and guidance to support TB advocacy, treatment, and care, with a focus on marginalized populations. It also provides strategies for addressing barriers to care, promoting patient-centered approaches, and advocating for policy changes to strengthen global TB prevention and control efforts.
This video-based HIV and STI prevention intervention designed for patients in STI clinic waiting rooms. This video aims to increase HIV treatment initiation and adherence as well as improve viral suppression and achieve undetectable viral load among patients.
This video explains Doxy PEP, a preventive option for common STDs like syphilis, gonorrhea, and chlamydia. It highlights the importance of taking doxycycline within 72 hours of potential exposure, ideally within 24 hours.
Contact organization for eligibility
Contact organization for eligibility
This webpage provides the Vaccine Information Statement (VIS) for the hepatitis B vaccine, detailing the vaccine's purpose, the diseases it prevents, the recommended vaccination schedule, potential side effects, and important information for healthcare providers. It serves as an essential resource for understanding the importance of hepatitis B vaccination.
This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.
This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.
